scholarly article | Q13442814 |
P50 | author | Michael Joannidis | Q88062375 |
P2093 | author name string | Stefan Weiler | |
Stefan Dunzendorfer | |||
Romuald Bellmann | |||
Elisabeth Überlacher | |||
Eva Stienecke | |||
Julia Schöfmann | |||
P2860 | cites work | Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury | Q21195041 |
Invasive aspergillosis in the intensive care unit | Q28306909 | ||
Amphotericin B colloidal dispersion. Pre-clinical review | Q33679607 | ||
Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats | Q33744215 | ||
Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans | Q34113512 | ||
Transection of the oesophagus for bleeding oesophageal varices | Q34211834 | ||
Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. | Q34480866 | ||
Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients | Q35136556 | ||
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/ | Q37164067 | ||
Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations. | Q37409856 | ||
Influence of albumin dialysis on pharmacokinetics of amphotericin B colloidal dispersion and amphotericin B lipid complex. | Q38463373 | ||
Altered pharmacokinetics of voriconazole in a patient with liver cirrhosis. | Q42627513 | ||
Determination of amphotericin B, liposomal amphotericin B, and amphotericin B colloidal dispersion in plasma by high-performance liquid chromatography | Q43725025 | ||
Amphotericin B lipid formulations in critically ill patients on continuous veno-venous haemofiltration | Q44342593 | ||
Differences in pharmacokinetics of amphotericin B lipid formulations despite clinical equivalence | Q44453839 | ||
Pharmacokinetics of micafungin in healthy volunteers, volunteers with moderate liver disease, and volunteers with renal dysfunction | Q46711313 | ||
Amphotericin B tissue distribution in autopsy material after treatment with liposomal amphotericin B and amphotericin B colloidal dispersion | Q48575634 | ||
Amphotericin B in the treatment of Candida cholecystitis | Q50156282 | ||
AmBisome (liposomal amphotericin B): a comparative review. | Q52531516 | ||
Excretion Pathways of Amphotericin B | Q66962115 | ||
Biliary excretion of amphotericin B deoxycholate and amphotericin B lipid complex | Q73133659 | ||
Anidulafungin does not require dosage adjustment in subjects with varying degrees of hepatic or renal impairment | Q80050361 | ||
Invasive aspergillosis in critically ill patients without malignancy | Q80269940 | ||
Pharmacokinetics of voriconazole during continuous venovenous haemodiafiltration | Q81251244 | ||
Pharmacokinetics of caspofungin in a critically ill patient with liver cirrhosis | Q84264833 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | amphotericin B | Q412223 |
pharmacokinetics | Q323936 | ||
P304 | page(s) | 5414-5418 | |
P577 | publication date | 2012-07-30 | |
P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
P1476 | title | Pharmacokinetics of amphotericin B colloidal dispersion in critically ill patients with cholestatic liver disease | |
P478 | volume | 56 |
Q26740363 | Fungal diseases: could nanostructured drug delivery systems be a novel paradigm for therapy? |
Q92446036 | Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy |
Q38681635 | Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients |
Q60175850 | Pre-Existing Liver Disease and Toxicity of Antifungals |
Q35148135 | Therapeutic monitoring of amphotericin B in Saudi ICU patients using UPLC MS/MS assay |
Search more.